Rabies Diagnostics Market

Rabies Diagnostics Market Size (2024 to 2029)

The global rabies diagnostics market size is valued at USD 1.69 Billion in 2024 and is anticipated to reach USD 2.34 Billion by 2029 with a CAGR of 6.8% during the forecast period.

Rabies is a viral disease that often transmits through the bite of a rabid animal, which can be preventable. The rabies virus affects the central nervous system of mammals, causing disease in the brain and death. Most wild animals like bats, raccoons, foxes, and skunks are infected by the rabies virus each year, according to the Centers for Disease Control and Prevention (CDC). The primary symptoms include flu, fever, weakness, and headache, lasting for days. Then, the symptoms progress to cerebral dysfunction, anxiety, confusion, and other symptoms. 

Global Rabies Diagnostics Market Drivers:

The increasing incidence of rabies across the globe is majorly contributing to the growth of the global rabies diagnostics market. The rising dog bite cases are fuelling the adoption of rabies diagnostics as dogs are highly prone to rabies infection through which humans are infected. According to the Centers for Disease Control and Prevention (CDC), each year, approximately 59,000 deaths occur worldwide. It also stated that control of dog rabies with animal vaccination programs and eliminating stray dogs are expected to reduce the incidence of human rabies. Dog rabies remains common in most countries, and exposure to these rabid dogs is still the cause of over 99% of human rabies deaths worldwide. The increasing number of government and healthcare organizations' collaborations to develop novel detection assays fuels the global market. For Instance, WHO, in collaboration with other healthcare agencies, is involved in the promotion of research endeavors for rabies control across the world. WHO also released various documents illustrating the disease control measures. These activities are expected to increase awareness regarding the disease and diagnostic methods among the people, propelling the rabies diagnostics market revenue. 

The growing technological advancements in the healthcare industry are increasing diagnostic services and using various advanced technologies in diagnostics, which is expected to augment the global market revenue. The rapid and accurate laboratory diagnosis of rabies is essential in humans and animals to avoid the risk of death, increasing the demand for rabies diagnostics. The surging healthcare expenditure and increasing awareness among the people regarding the virus and the early diagnosis and treatment measures are estimated to escalate the rabies diagnostics market value.

The growing research in the healthcare industry and the increasing healthcare expenditure by developing countries are expected to expand the diagnostic methods with novel developments, creating lucrative opportunities for global market growth during the forecast period. The increasing collaborations between the government and other public organizations to run campaigns and programs will increase awareness among people regarding early diagnosis and treatment options. This awareness is expected to enhance the adoption of rabies diagnostics by raising the market revenue.

Global Rabies Diagnostics Market Restraints:

The primary restraining factor for the global rabies diagnostics market is the increasing vaccination, which will obstruct the disease and decrease the adoption rate of the rabies diagnosis. The high cost associated with the diagnostic methods, which is difficult to afford for people with low or middle economic status, is expected to hamper the rabies diagnostics market revenue. The process of diagnosis is different in humans and animals. The animals need one diagnostic test to confirm the disease, whereas humans require various tests like saliva, serum, spinal fluid, and other samples to confirm the disease. These factors may be time-consuming and are estimated to limit the global rabies diagnostic market expansion.

There is a need for more awareness among the people as most of the low economic countries are less aware of the diseases and neglect them, which in turn affects the rabies diagnostics expected to hamper the market growth. Most of the smaller and remote laboratories do simple stain tests, which cost less and may give negative results. The accuracy associated with these tests is low, and then again transported to the national laboratory, which increases the expense of the procedure and may cause an effective control of the infection. This kind of practice poses challenges to the adoption of rabies diagnostics. 

Impact of COVID-19 on the rabies diagnostics market:

The Pandemic negatively impacted the rabies diagnostics market due to more healthcare concerns in emergency cases. Due to COVID-19, the vaccination supply was stopped for the dogs due to stringent lockdown regulations. The disruptions prevented dog bite victims from seeking post-exposure prophylaxis (PEP) due to travel restrictions and the shutdown of anti-rabies clinics. The Pandemic has highly impacted low and middle-income countries where human rabies cases are high in count.

REPORT COVERAGE:

This research report on the global rabies diagnostics market is segmented and sub-segmented based on type, technology, end-use, and region.

Global Rabies Diagnostics Market - By Type:

• Fluorescent Antibody Test
• Histologic Examination
• Immunohistochemical Tests
• Amplification Methods
• Serology Tests

The fluorescent antibody testing segment dominated global rabies diagnostics due to its broad adoption worldwide and is considered the gold standard. The fluorescent antibody test is highly recommended by the World Health Organization and the World Organization for Animal Health, which boosts segment growth by raising global market revenue. This test is expected to offer more specificity and sensitivity than other diagnostic methods. 

The amplification methods segment is expected to have lucrative growth during the forecast period as they are considered promising assays. These assays are developed as adjuncts for conventional antemortem and postmortem testing tests. 

Global Rabies Diagnostics Market - By Technology:

• ELISA/Immunohistochemistry
• Chromatography Techniques
• PCR 
• Others

The ELISA held the largest market share due to the higher penetration of products based on ELISA/Immunohistochemistry protocols. Immunohistochemistry-based methods are expected to offer various advantages, which has led to wide adoption of the technology and is projected to augment the segment growth in the upcoming years. This technology includes various methods like fluorescent antibody testing, histologic examination, and amplification methods, which are boosting the adoption rate of the technology by increasing the global market share. These are cost-effective but time-consuming options, and these assays involve the frozen and preserved s and the adoption rate. 

The PCR segment is projected to have lucrative growth during the forecast period due to its capability to perform antemortem and postmortem rabies testing and its capacity to analyze various samples in one test. 

Global Rabies Diagnostics Market - By End-Use:

• Hospitals
• Diagnostic Centers
• Cancer Palliative Care clinics
• Others

The hospital's segment dominated the global market due to its broad adoption among people. The presence of advanced technology-incorporated laboratories, government support, and funding is increasing the segment's growth. The presence of skilled healthcare professionals is gaining traction among those who prefer hospitals, enhancing the global market revenue. 

The diagnostic centers segment is projected to grow significantly during the forecast period due to increasing standards and output of diagnostic methods. Diagnostic centers are growing worldwide with advanced technological methods and equipment, gaining people's trust and influencing global market revenue. 

Global Rabies Diagnostics Market - By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

The North American region held the largest market share in the global market revenue and is expected to continue the domination during the forecast period. The presence of major key players and the advanced healthcare system with prominent diagnostic equipment and methods is driving the global rabies diagnostics market revenue. The increasing number of rabies infection cases across the region demands rabies diagnostic methods to influence market expansion. According to the Centers for Disease Control and Prevention, around 120,000 animals are tested for rabies in the U.S. annually. The increasing R&D activities in the region are due to the presence of prominent research centers in countries like the U.S. and Canada. 

The Asia Pacific region is projected to grow significantly during the forecast period, with the highest CAGR due to increasing rabies infection. According to WHO, around 31000 human deaths are observed in Asia annually, and it also states that approximately 2000 deaths are reported each year for a decade in China. The growing government initiatives for bringing awareness among the people to reduce fatal cases and increase early diagnosis are expected to escalate the market growth in the upcoming years. 

Key Market Players:

MyBioSource.com, Aviva Systems Biology Corporation, Norgen Biotek Corporation, Merck KGaA, Bio-Rad Laboratories, Inc., Creative Diagnostics, Demeditec Diagnosis GmbH, Express Biotech International Inc., Abbexa Ltd., BioNote Inc are some of the key market players in the rabies diagnostics market.

Recent Market Developments:

• In April 2022, Cadila Pharmaceuticals launched the first novel three-dose rabies vaccine, ThRabis, a recombinant nano-particle-based G protein vaccine using virus-like particle technology.